These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 32889877
21. Abdominal symptoms: do they disappear after cholecystectomy? Berger MY, Olde Hartman TC, Bohnen AM. Surg Endosc; 2003 Nov; 17(11):1723-8. PubMed ID: 12802649 [Abstract] [Full Text] [Related]
22. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease. De Vries DR, Van Herwaarden MA, Baron A, Smout AJ, Samsom M. Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924 [Abstract] [Full Text] [Related]
25. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A. J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945 [Abstract] [Full Text] [Related]
26. A randomized controlled trial to compare a restrictive strategy to usual care for the effectiveness of cholecystectomy in patients with symptomatic gallstones (SECURE trial protocol). de Reuver PR, van Dijk AH, Wennmacker SZ, Lamberts MP, Boerma D, den Oudsten BL, Dijkgraaf MG, Donkervoort SC, Roukema JA, Westert GP, Drenth JP, van Laarhoven CJ, Boermeester MA. BMC Surg; 2016 Jul 13; 16(1):46. PubMed ID: 27411788 [Abstract] [Full Text] [Related]
27. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia. Futagami S, Yamawaki H, Shimpuku M, Izumi N, Wakabayashi T, Kodaka Y, Nagoya H, Shindo T, Kawagoe T, Sakamoto C. J Nippon Med Sch; 2013 Jul 13; 80(5):362-70. PubMed ID: 24189354 [Abstract] [Full Text] [Related]
28. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors. von Wulffen M, Talley NJ, Hammer J, McMaster J, Rich G, Shah A, Koloski N, Kendall BJ, Jones M, Holtmann G. Dig Dis Sci; 2019 Feb 13; 64(2):480-486. PubMed ID: 30368683 [Abstract] [Full Text] [Related]
29. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones]. Zhao L, Song W, Zhu P, Zhang Y, Bu P. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct 13; 34(10):1168-72. PubMed ID: 25509256 [Abstract] [Full Text] [Related]
30. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Shiha MG, Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, Tai FWD, Afify S, Aziz I. Neurogastroenterol Motil; 2021 Oct 13; 33(10):e14121. PubMed ID: 33719130 [Abstract] [Full Text] [Related]
31. Prevalence of Irritable Bowel Syndrome, Functional Dyspepsia and their Overlap in Bulgaria: a Population-Based Study. Nakov R, Dimitrova-Yurukova D, Snegarova V, Uzunova M, Lyutakov I, Ivanova M, Madzharova K, Valkov H, Hristova R, Ivanov K, Kosturkov I, Valcheva G, Nakov N, Nakov V. J Gastrointestin Liver Dis; 2020 Sep 09; 29(3):329-338. PubMed ID: 32919417 [Abstract] [Full Text] [Related]
32. High Prevalence of Small Intestinal Bacterial Overgrowth among Functional Dyspepsia Patients. Tziatzios G, Gkolfakis P, Papanikolaou IS, Mathur R, Pimentel M, Damoraki G, Giamarellos-Bourboulis EJ, Dimitriadis G, Triantafyllou K. Dig Dis; 2021 Sep 09; 39(4):382-390. PubMed ID: 33011725 [Abstract] [Full Text] [Related]
33. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Aliment Pharmacol Ther; 2008 Aug 01; 28(3):334-43. PubMed ID: 19086237 [Abstract] [Full Text] [Related]
34. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan. Ono M, Kato M, Miyamoto S, Tsuda M, Mizushima T, Ono S, Nakagawa M, Mabe K, Nakagawa S, Muto S, Shimizu Y, Kudo M, Katsuki S, Meguro T, Sakamoto N. J Gastroenterol; 2018 Aug 01; 53(8):916-923. PubMed ID: 29305648 [Abstract] [Full Text] [Related]
35. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A, San Felice del Benaco Study Investigators. Am J Gastroenterol; 2012 Jun 01; 107(6):891-9. PubMed ID: 22525306 [Abstract] [Full Text] [Related]
38. Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT. Ivashkin VT, Poluektova EA, Glazunov AB, Putilovskiy MA, Epstein OI. BMC Gastroenterol; 2019 Dec 31; 20(1):2. PubMed ID: 31892312 [Abstract] [Full Text] [Related]
39. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Lu CL, Lang HC, Chang FY, Chen CY, Luo JC, Wang SS, Lee SD. Scand J Gastroenterol; 2005 Apr 31; 40(4):402-11. PubMed ID: 16028434 [Abstract] [Full Text] [Related]
40. The postcholecystectomy syndrome. A role for duodenogastric reflux. Abu Farsakh NA, Stietieh M, Abu Farsakh FA. J Clin Gastroenterol; 1996 Apr 31; 22(3):197-201. PubMed ID: 8724257 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]